2015冷泉港亚洲-肿瘤免疫及免疫疗法

Organizers

Major Topics:
1. Defining tumor antigens and immunogenicity
2. Vaccine-based immunotherapy
3. Immune checkpoint blockade
4. Antibody therapy
5. Adoptive T cell therapy
6. Gut microbiota, immunity and cancer
7. Inflammation, tumor microenvironment and immune escape
8. New approach to cancer immunotherapy

Abstract Due July 3, 2015

Keynote Speaker:
Lieping Chen, Yale University School of Medicine, USA
 

Invited Speakers:
Nina Bhardwaj, Icahn School of Medicine at Mt Sinai, Tisch Cancer Institute, USA
Xuetao Cao, Chinese Academy of Medical Sciences/The Second Military Medical University, CHINA
Madhav Dhodapkar, Yale University, USA
Olivera Finn, University of Pittsburgh School of Medicine, USA
Holbrook Kohrt, Stanford School of Medicine, USA
Ming Li, Memorial Sloan-Kettering Cancer Center, USA
Ofer Mandelboim, The Hebrew University of Jerusalem, ISRAEL
Michael Platten, University of Heidelberg Medical Center, GERMANY
Zhihai Qin, Institute of Biophysics, CAS, China
Michel Sadelain, Memorial Sloan Kettering Cancer Center, USA
Shimon Sakaguchi, Osaka University, JAPAN
Tadatsugu Taniguchi, University of Tokyo Institute of Industrial Science, JAPAN
Kris Thielemans, Vrije Universiteit Brussel, BELGIUM
Rongfu Wang, Houston Methodist Research Institute, USA
Laurence Zitvogel, Institut Gustave Roussy(IGR), FRANCE
Weiping Zou, University of Michigan Medical School, USA
 

Tel: +86-512-62729029; Email: meetings@csh-asia.org

Address: No. 299, Qiyue Road, Suzhou, China

www.csh-asia.org